This site is an independent educational resource for research compounds. We do not sell, distribute, or endorse human consumption of any compound. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.
Also known as: LY3305677
Dual GLP-1/glucagon receptor agonist.
A GLP-1/GIP/glucagon triple receptor agonist developed by Eli Lilly. Similar to retatrutide, it targets metabolic pathways through three hormonal axes with the addition of cagrilintide (amylin analog) for enhanced satiety.
A GLP-1/GIP/glucagon triple receptor agonist developed by Eli Lilly. Similar to retatrutide, it targets metabolic pathways through three hormonal axes with the addition of cagrilintide (amylin analog) for enhanced satiety.
IUPAC Name
Not yet available
CAS Number
2498263-63-9
Molecular Formula
C232H358N60O79S
Molecular Mass
5045.0 g/mol
Create a free account to:
Join 2,800+ researchers
Create a free account to:
Join 2,800+ researchers
Personal or family history of MTC. MEN 2. Pancreatitis. Severe GI disease. Pregnancy or breastfeeding.
Research Disclaimer
This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.
$89.99
$17.9980
1
1
vial
Weight Loss
A selective NNMT inhibitor that enhances fat metabolism by increasing cellular NAD+ and energy expenditure..
Weight Loss
Mitochondrial protonophore for fat metabolism.
Weight Loss
Quad agonist weight loss blend.
Weight Loss
Amino acid for fat metabolism and energy.
Weight Loss
Lipotropic compound blend injection.
Weight Loss
NAD+ and carnitine amino blend for energy and metabolism.
View Full Dosage Guide →
Protocols, calculator & safety for Mazdutide
36 PubMed studies
Data Completeness
88%Research Credibility
Molecular Weight
5045.0 g/mol
CAS Number
2498263-63-9
Trial Phase
Preclinical
Research Disclaimer
This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use.
Dual GLP-1/glucagon receptor agonist
Mazdutide is available in vial form.
Prices start at $89.99 across 1 verified vendor.
Compare prices, payment methods, shipping, and COA scores across 1 vendor.
Weight Loss
A selective NNMT inhibitor that enhances fat metabolism by increasing cellular NAD+ and energy expenditure..
Weight Loss
Mitochondrial protonophore for fat metabolism.
Weight Loss
Quad agonist weight loss blend.
Weight Loss
Amino acid for fat metabolism and energy.
Weight Loss
Lipotropic compound blend injection.
Weight Loss
NAD+ and carnitine amino blend for energy and metabolism.